On the multimodal front, transformer-based fusion models have been proposed, such as a vision transformer combining MRI and PET for AD diagnosis and MRI-based deep networks to predict established AT(N) biomarker profiles (amyloid/tau/neurodegeneration) as surrogates of pathology. This evidence concerns the gene MAPT and Alzheimer disease.